Thyroid and other Endocrine System Cancers

Cervix, Colon, Esophagus, Kidney, Larynx, Lip, Oral Cavity and Pharynx, Lung, Phase I, Rectum, Small Intestine, Stomach, ThyroidA Phase 1, Open-label, Multicenter, Dose Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of KQB168 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Malignancies
Other Endocrine SystemA Randomized, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Paltusotine in Adults With Carcinoid Syndrome Due to Well-Differentiated Neuroendocrine Tumors
ThyroidA Phase III Study of Targeted Therapy vs. Chemotherapy in Patients with Thyroid Cancer
Anus, Bones and Joints, Breast, Colon, Esophagus, Kidney, Larynx, Lip, Oral Cavity and Pharynx, Liver, Lung, Ovary, Pancreas, Prostate, Rectum, Small Intestine, Soft Tissue, Stomach, ThyroidPROgram to address psychosocial Support, clinical outcomes, and genomic insights for Patients with EaRly onset cancers
Other Endocrine System, PancreasRandomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide Versus Observation in High-Risk Pancreatic Neuroendocrine TumorsPrincipal Investigator: Pamela L. Kunz